QUIT
Achieve Life Sciences Inc. · NASDAQ
- Market cap
- $695.4M
52-week range59% up the range
$2.63$8.61
Achieve Life Sciences Inc. (QUIT) is a Biotechnology: In Vitro & In Vivo Diagnostic Substances company listed on NASDAQ. There were no new wire items for QUIT in the last 30 days.
QUIT rankings
Price$6.16-1.44 (-18.96%)
2026-08-142026-11-16
Financial highlights
Full financials- Net income, TTM
- -$111.71M
- Cash
- $59.74M
For the twelve months ended Sep 30, 2026, from SEC filings. Not investment advice.
Latest news
0 itemsNo recent news.
QUIT FAQ
7 questionsWhat does Achieve Life Sciences Inc. do?
AchieveRx, The Quit Company (Nasdaq: ACHV; QUIT effective November 10, 2026 ; formerly doing business as Achieve Life Sciences, Inc. ) is a late-stage pharmaceutical company with a singular focus on nicotine dependence. AchieveRx's mission is to develop medicine for people who want to quit smoking or vaping. That medicine is cytisinicline, an investigational compound. Three ideas guide the Company: simplicity, science, and second chances, for good.Is QUIT profitable?
No. Achieve Life Sciences Inc. reported a net loss of $111.71M for the twelve months ended Sep 30, 2026.How much cash and debt does QUIT have?
Achieve Life Sciences Inc. reported $59.74M in cash and cash equivalents on its most recent balance sheet in SEC filings.Where does QUIT stock trade?
Achieve Life Sciences Inc. (QUIT) is listed on NASDAQ.What sector and industry is QUIT in?
Achieve Life Sciences Inc. operates in the Health Care sector, Biotechnology: In Vitro & In Vivo Diagnostic Substances industry.What companies are similar to QUIT?
Notable peers in the same industry include LNTH (Lantheus Holdings Inc.), NTLA (Intellia Therapeutics Inc.), ACHV (Achieve Life Sciences Inc.), ORKA (Oruka Therapeutics Inc.), CLDX (Celldex Therapeutics Inc.). Compare QUIT side-by-side with any of them on Quantisnow.How can I track QUIT on Quantisnow?
Quantisnow aggregates Achieve Life Sciences Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow QUIT to receive live email and push alerts on every new disclosure.